UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Co-occurring conditions in children with Down syndrome and autism: a retrospective study

Journal of neurodevelopmental disorders, 2023-03, Vol.15 (1), p.9-9, Article 9

2023

Volltextzugriff (PDF)

Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Frontiers in cardiovascular medicine, 2023-08, Vol.10, p.1225654-1225654

2023

Volltextzugriff (PDF)

Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder

Journal of neurodevelopmental disorders, 2023-10, Vol.15 (1), p.1-35, Article 35

2023

Volltextzugriff (PDF)

Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder

Translational psychiatry, 2023-08, Vol.13 (1), p.276-11, Article 276

2023

Volltextzugriff (PDF)

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

Academic radiology, 1999-05, Vol.6 (5), p.282-291

1999

Volltextzugriff (PDF)

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)

American journal of neuroradiology : AJNR, 2015-09, Vol.36 (9), p.1589-1598

2015

Volltextzugriff (PDF)

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines

European radiology, 2011-12, Vol.21 (12), p.2527-2541

2011

Volltextzugriff (PDF)

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

European radiology, 2013-02, Vol.23 (2), p.307-318

2013

Volltextzugriff (PDF)

Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine

Radiology, 2005-02, Vol.234 (2), p.399-408

2005

Volltextzugriff (PDF)

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Lancet neurology, 2023-05, Vol.22 (5), p.395-406

2023

Volltextzugriff (PDF)

Adverse childhood experiences and the development of Down syndrome regression disorder

American journal of medical genetics. Part A, 2023-07, Vol.191 (7), p.1769-1782

2023

Volltextzugriff (PDF)

MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis

American journal of roentgenology (1976), 2008-10, Vol.191 (4), p.1129-1139

2008

Volltextzugriff (PDF)

Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID‐19 pandemic

European journal of neurology, 2022-04, Vol.29 (4), p.1181-1186

2022

Volltextzugriff (PDF)

MRI safety update 2008: part 2, screening patients for MRI

American journal of roentgenology (1976), 2008-10, Vol.191 (4), p.1140

2008

Volltextzugriff (PDF)

Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2009-07, Vol.181 (7), p.652

2009

Volltextzugriff (PDF)

Diagnostic efficacy of SonoVue®, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound : a multicentre study

British journal of radiology, 2006, Vol.79 (937), p.44-51

2006

Volltextzugriff (PDF)

Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions

American journal of roentgenology (1976), 2000-10, Vol.175 (4), p.1111-1120

2000

Volltextzugriff (PDF)

Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

Orphanet journal of rare diseases, 2022-03, Vol.17 (1), p.96-96, Article 96

2022

Volltextzugriff (PDF)

Emerging clinical applications for contrast echocardiography

European heart journal supplements, 2002-03, Vol.4 (suppl-C), p.C8-C11

SPINAZZI, A

2002

Volltextzugriff (PDF)

Reply

American journal of neuroradiology : AJNR, 2016-03, Vol.37 (3), p.E22-E24

2016

Volltextzugriff (PDF)

Reply

American journal of neuroradiology : AJNR, 2016-03, Vol.37 (3), p.E22-E24

2016

Volltextzugriff (PDF)

Late adverse reactions to intravascular iodine based contrast media: an update

European radiology, 2011-11, Vol.21 (11), p.2305-2310

2011

Volltextzugriff (PDF)

MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver

Academic radiology, 1998-04, Vol.5, p.S86-S89

1998

Volltextzugriff (PDF)

Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application

Radiology, 1996-05, Vol.199 (2), p.513-520

1996

Volltextzugriff (PDF)

Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases

Neuromuscular disorders : NMD, 2012-12, Vol.22 (3-3), p.S226-S229

2012

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(194)
Life Sciences & Biomedicine
(188)
Humans
(159)
Male
(89)
Female
(75)
Radiology, Nuclear Medicine & Medical Imaging
(64)
Adult
(59)
Middle Aged
(56)
Animals
(48)
Aged
(44)
Biological And Medical Sciences
(44)
Neurosciences & Neurology
(36)
Contrast Media
(35)
Medical Sciences
(35)
Clinical Neurology
(33)
Meglumine - Analogs & Derivatives
(33)
Contrast Media - Adverse Effects
(32)
Medicine, Research & Experimental
(30)
Research & Experimental Medicine
(30)
Life Sciences
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Co-occurring conditions in children with Down syndrome and autism: a retrospective study

Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder

Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adverse childhood experiences and the development of Down syndrome regression disorder

MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis

Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID‐19 pandemic

MRI safety update 2008: part 2, screening patients for MRI

Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)

Diagnostic efficacy of SonoVue®, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound : a multicentre study

Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions

Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

Emerging clinical applications for contrast echocardiography

Reply

Reply

Late adverse reactions to intravascular iodine based contrast media: an update

MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver

Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application

Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases

Suchergebnisse filtern